Latest News - Thermo Fisher Scientific
Top Corporates Hub
Thermo Fisher Scientific
Global Biopreservation Market Set to Surpass USD 7.1 Billion by 2029 | MarketsandMarkets™
08.10.2025 15:00
Advancements in healthcare expenditure, research investment, and regenerative medicine are fueling growth while storage logistics remain a critical challengeDelray Beach, FL,, Oct. 08, 2025 (GLOBE NEWSWIRE) -- formation, and contamination risks threaten sample viability. Ensuring consistent global transportation standards will be a key differentiator for market leaders, particularly as demand for international collaboration and sample sharing increases. Request Sample Pages : https://www.markets
Bank of America Securities Maintains a Buy Rating on Vaxcyte (PCVX)
08.10.2025 04:57
Vaxcyte, Inc. (NASDAQ:PCVX) is one of the best biotech stocks with high potential. In a report released on October 3, Jason Gerberry from Bank of America Securities maintained a Buy rating on Vaxcyte, Inc. (NASDAQ:PCVX) and set a price target of $134.00. In other news, Vaxcyte, Inc. (NASDAQ:PCVX) reported on September 30 that it entered […]
Evercore ISI Group Maintains Thermo Fisher Scientific (TMO) Outperform Recommendation
08.10.2025 00:06
Bernstein Reaffirms Outperform Rating on Thermo Fisher (TMO) After Investor Roadshow
02.10.2025 06:55
Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the top picks for a retirement portfolio. On September 22, following talks with management, Bernstein reaffirmed its Outperform rating and $570 price target for Thermo Fisher Scientific Inc. (NYSE:TMO). Rafael Tejada, Head of Investor Relations at Thermo Fisher, took part in a non-deal roadshow in Toronto and Montreal […]
OutSystems Announces General Availability of Agent Workbench, Empowering Enterprises to Drive Business Impact with Agentic Systems
01.10.2025 02:00
OutSystems, the leading AI-powered low-code development platform, today announced the general availability of OutSystems Agent Workbench. Agent Workbench empowers enterprises to unlock the business value of AI and agentic systems, making it simple to create and orchestrate intelligent AI agents across use cases, departments, data sets and workflows. Hundreds of customers and partners — companies such as Axos Bank, Thermo Fisher Scientific, The Arch Company, Grihum Housing Finance, and TeamWork —
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
01.10.2025 00:00
WALTHAM, Mass., October 01, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") announced today that it has priced an offering of $2.5 billion aggregate principal amount (the "Offering") of the following notes:
Insiders At Thermo Fisher Scientific Sold US$2.0m In Stock, Alluding To Potential Weakness
29.09.2025 14:02
The fact that multiple Thermo Fisher Scientific Inc. ( NYSE:TMO ) insiders offloaded a considerable amount of shares...
The Baltics: a region punching above its weight on the global life sciences stage
26.09.2025 12:24
This year’s Life Sciences Baltics conference in Vilnius, Lithuania, amply demonstrated the maturation and growing value proposition of life sciences in the country and across the wider Baltics region.
3 Reasons TMO is Risky and 1 Stock to Buy Instead
26.09.2025 04:02
Over the past six months, Thermo Fisher’s shares (currently trading at $457.50) have posted a disappointing 10.9% loss, well below the S&P 500’s 15.7% gain. This might have investors contemplating their next move.
Dr. Park CDMO Selects Thermo Fisher Scientific to Equip New Viral Vector Manufacturing Facility
25.09.2025 00:00
WALTHAM, Mass., September 25, 2025--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Dr. Park, an emerging viral vector contract development and manufacturing organization (CDMO) based in South Korea, has selected Thermo Fisher to provide advanced bioreactors and consumables for its newest facility.
Thermo Fisher: A Wide-Moat Leader With Multi-Year Growth Ahead
24.09.2025 08:37
Thermo Fisher is well positioned as a mission-critical partner in life sciences, with a recurring revenue base and strong end-to-end solutions.
Chinese start-up breaks US monopoly in 3D imaging of biomolecules, aims for IPO in 2027
17.09.2025 10:30
Shuimu BioSciences, a Chinese start-up specialising in advanced imaging devices for viruses and smaller biomolecules, is aiming for an initial public offering in 2027 after selling its first self-developed product this year, according to CEO Allen Guo Chunlong. The company focuses on cryo-electron microscopy (Cryo-EM), a technique that involves firing beams of electrons at flash-frozen specimens to capture thousands of images. The images are then used to reconstruct precise three-dimensional str
Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Site
02.09.2025 13:15
WALTHAM, Mass., September 02, 2025--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the completion of its acquisition of Sanofi’s state-of-the-art sterile fill-finish and packaging site in Ridgefield, New Jersey, marking an expansion of the companies’ strategic partnership to enable additional U.S. drug product manufacturing. The terms of the deal were not disclosed. The Ridgefield facility is now part of Thermo Fisher's pharma services business wit
Thermo Fisher Scientific Completes Acquisition of Solventum’s Purification and Filtration Business
02.09.2025 13:00
WALTHAM, Mass., September 02, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher"), the world leader in serving science, today announced the completion of its acquisition of the Purification & Filtration business of Solventum (NYSE: SOLV) for approximately $4.0 billion in cash. With the transaction complete, the business, which is now Thermo Fisher’s Filtration and Separation business, is part of the Life Sciences Solutions segment.
Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc.
02.09.2025 13:00
Solventum (NYSE: SOLV) today announced it has completed the sale of its Purification & Filtration business ("P&F") to Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher") for $4.0 billion in cash before customary adjustments.
Thermo Fisher Scientific's Valuation: Assessing Growth Potential After New Facility and Nalgene Product Launches
02.09.2025 11:07
Thermo Fisher Scientific (TMO) just threw a spotlight on its growth ambitions by opening a state-of-the-art, carbon neutral manufacturing center in Mebane, North Carolina. The 375,000-square-foot facility is built for high-speed, automated production of laboratory pipette tips, which are critical tools for medical research and diagnostics. Not stopping there, the company is also pumping up its consumer brand with the launch of Nalgene Outdoor's GloWyld bottle collection, blending...
ERMA Systems Welcomes Israel Aker, PharmD, RPh, Thermo Fisher Scientific to Advisory Board to Strengthen Medical Affairs Strategy
26.08.2025 12:00
MIAMI, August 26, 2025--ERMA Systems, the AI-powered SaaS company transforming how Life Sciences organizations manage their Promotional and Medical Review Committee (PRC/MRC) processes, proudly announces the appointment of Israel Aker, PharmD, RPh, to its Advisory Board. A seasoned expert in Medical Affairs with deep experience at leading biopharmaceutical organizations, Dr. Aker brings invaluable insight as ERMA deepens its impact across the Life Sciences ecosystem.
How the Recent 22% Surge Shapes Thermo Fisher’s True Value in 2025
21.08.2025 10:17
If you have been watching Thermo Fisher Scientific’s stock lately, you are definitely not alone. With shares closing at $494.81 and recent moves that have caught the eye of both cautious bears and optimistic bulls alike, there are real questions about where TMO goes next. Should you buy in, hold tight, or consider cashing out? Let’s break down what is driving these price shifts. Over the past month, Thermo Fisher Scientific's stock has climbed roughly 22%, suggesting renewed optimism about...
Pharmaceutical Inspection Machines Industry Report 2025-2030: Led by Key Players Mettler-Toledo, Thermo Fisher Scientific, Sartorius, Syntegon Technology, and Krones
19.08.2025 08:34
Digital transformation, automation, AI, and regional supply chain shaping present market opportunitiesDublin, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Inspection Machines Market by Machine Type (Label Inspection, Leak Testing, Seal Inspection), Packaging Type (Ampoules, Bottles, Pouches), Technology, Automation Level, End User - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The pharmaceutical inspection machines market is evolving quickly in